Beauty Health (SKIN)
Beauty Health Statistics
Share Statistics
Beauty Health has 125.25M shares outstanding. The number of shares has increased by 0.56% in one year.
Shares Outstanding | 125.25M |
Shares Change (YoY) | 0.56% |
Shares Change (QoQ) | 0.08% |
Owned by Institutions (%) | 59.04% |
Shares Floating | 73.27M |
Failed to Deliver (FTD) Shares | 634 |
FTD / Avg. Volume | 0.11% |
Short Selling Information
The latest short interest is 8.73M, so 7.03% of the outstanding shares have been sold short.
Short Interest | 8.73M |
Short % of Shares Out | 7.03% |
Short % of Float | 11.33% |
Short Ratio (days to cover) | 13.42 |
Valuation Ratios
The PE ratio is -6.77 and the forward PE ratio is -9.53. Beauty Health's PEG ratio is 0.07.
PE Ratio | -6.77 |
Forward PE | -9.53 |
PS Ratio | 0.59 |
Forward PS | 0.4 |
PB Ratio | 3.8 |
P/FCF Ratio | 21.08 |
PEG Ratio | 0.07 |
Enterprise Valuation
Beauty Health has an Enterprise Value (EV) of 638.79M.
EV / Earnings | -21.95 |
EV / Sales | 1.91 |
EV / EBITDA | 43.93 |
EV / EBIT | -9.43 |
EV / FCF | 68.39 |
Financial Position
The company has a current ratio of 7, with a Debt / Equity ratio of 10.97.
Current Ratio | 7 |
Quick Ratio | 5.99 |
Debt / Equity | 10.97 |
Total Debt / Capitalization | 91.64 |
Cash Flow / Debt | 0.03 |
Interest Coverage | -6.51 |
Financial Efficiency
Return on equity (ROE) is -0.56% and return on capital (ROIC) is -10.76%.
Return on Equity (ROE) | -0.56% |
Return on Assets (ROA) | -0.04% |
Return on Capital (ROIC) | -10.76% |
Revenue Per Employee | $434,712.61 |
Profits Per Employee | $-37,838.75 |
Employee Count | 769 |
Asset Turnover | 0.49 |
Inventory Turnover | 2.2 |
Taxes
Income Tax | -452K |
Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -70.5% in the last 52 weeks. The beta is 0.84, so Beauty Health's price volatility has been higher than the market average.
Beta | 0.84 |
52-Week Price Change | -70.5% |
50-Day Moving Average | 1.51 |
200-Day Moving Average | 1.6 |
Relative Strength Index (RSI) | 43.82 |
Average Volume (20 Days) | 592.88K |
Income Statement
In the last 12 months, Beauty Health had revenue of 334.29M and earned -29.1M in profits. Earnings per share was -0.05.
Revenue | 334.29M |
Gross Profit | 182.3M |
Operating Income | -67.77M |
Net Income | -29.1M |
EBITDA | 14.54M |
EBIT | -67.77M |
Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 370.06M in cash and 568.16M in debt, giving a net cash position of -198.09M.
Cash & Cash Equivalents | 370.06M |
Total Debt | 568.16M |
Net Cash | -198.09M |
Retained Earnings | -507.96M |
Total Assets | 685.68M |
Working Capital | 408.95M |
Cash Flow
In the last 12 months, operating cash flow was 16.13M and capital expenditures -6.79M, giving a free cash flow of 9.34M.
Operating Cash Flow | 16.13M |
Capital Expenditures | -6.79M |
Free Cash Flow | 9.34M |
FCF Per Share | 0.08 |
Margins
Gross margin is 54.53%, with operating and profit margins of -20.27% and -8.7%.
Gross Margin | 54.53% |
Operating Margin | -20.27% |
Pretax Margin | -8.84% |
Profit Margin | -8.7% |
EBITDA Margin | 4.35% |
EBIT Margin | -20.27% |
FCF Margin | 2.79% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -3.82% |
FCF Yield | 5.67% |
Analyst Forecast
The average price target for SKIN is $2, which is 52.7% higher than the current price. The consensus rating is "Hold".
Price Target | $2 |
Price Target Difference | 52.7% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Scores
Altman Z-Score | 0.25 |
Piotroski F-Score | 7 |